RETRACTED: An Innovative Tool for Evidence-Based, Personalized Treatment Trials in Mucopolysaccharidosis

Mucopolysaccharidosis (MPS) is a group of rare metabolic diseases associated with reduced life expectancy and a substantial unmet medical need. Immunomodulatory drugs could be a relevant treatment approach for MPS patients, although they are not licensed for this population. Therefore, we aim to pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiesinger, Anna-Maria, Bigger, Brian, Giugliani, Roberto, Lampe, Christina, Scarpa, Maurizio, Moser, Tobias, Kampmann, Christoph, Zimmermann, Georg, Lagler, Florian B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221776/
https://www.ncbi.nlm.nih.gov/pubmed/37242808
http://dx.doi.org/10.3390/pharmaceutics15051565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221776/
https://www.ncbi.nlm.nih.gov/pubmed/37242808
http://dx.doi.org/10.3390/pharmaceutics15051565

Ejemplares similares